Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+).
about
New insights into mitochondrial structure during cell death.Stereotaxical infusion of rotenone: a reliable rodent model for Parkinson's disease.A selective role for ARMS/Kidins220 scaffold protein in spatial memory and trophic support of entorhinal and frontal cortical neuronsMice lacking major brain gangliosides develop parkinsonism1-Methyl-4-phenylpyridinium stereotactic infusion completely and specifically ablated the nigrostriatal dopaminergic pathway in rhesus macaqueCharacterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: relevance to Parkinson's disease.Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse modelToxin models of mitochondrial dysfunction in Parkinson's disease.Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's diseaseModeling PD pathogenesis in mice: advantages of a chronic MPTP protocol.Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic interventionAnimal models of Parkinson's disease progressionWhat determines the molecular composition of abnormal protein aggregates in neurodegenerative disease?Chronic intraventricular administration of 1-methyl-4-phenylpyridinium as a progressive model of Parkinson's diseaseThe angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonismMPTP mouse models of Parkinson's disease: an update.Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long-Standing Model.Role of protein kinase Cdelta in paraquat-induced glial cell death.Orthotopic transplantation of immortalized mesencephalic progenitors (CSM14.1 cells) into the substantia nigra of hemiparkinsonian rats induces neuronal differentiation and motoric improvement.Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson's disease.PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.High doses of nicotinamide prevent oxidative mitochondrial dysfunction in a cellular model and improve motor deficit in a Drosophila model of Parkinson's disease.Coenzyme Q10 Prevents Mitochondrial Dysfunction and Facilitates Pharmacological Activity of Atorvastatin in 6-OHDA Induced Dopaminergic Toxicity in Rats.Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans.lncRNA MALAT1/miR-205-5p axis regulates MPP+-induced cell apoptosis in MN9D cells by directly targeting LRRK2.
P2860
Q30480195-07C9D263-2AF5-4885-9D52-FFEBDF4C124EQ30895929-55816F6C-53F5-4A26-ABFE-8BDA5E99C32BQ35000284-479DAEBA-0634-4554-B0AC-DFE324530AE7Q35161290-866E6C83-2550-46FD-A4BE-23F1F040A01CQ35641515-5662A00E-8D9E-45DD-8701-78513890D518Q35728704-E157BD73-9666-4CAA-B3CD-4E53E09E4464Q35750160-78EB70A6-BA15-4AFD-AABB-9B18EB532B9CQ35799141-ABA9ECB6-0970-4DBB-AFC3-4ACB1351CB68Q35830757-093F8BF9-97E9-4759-BD2A-1F0A970B544EQ36899298-A82153F1-9E36-46CC-BC6C-497D11C7C9F3Q36919403-F79169CC-6DB3-4A99-99A6-5678BF04B32EQ36924624-4C254368-3CAC-4CF2-8967-8590CE3164C9Q37146578-073A3052-E1CF-4BAF-9B93-BE98CFA44B65Q37201142-57EB50CB-B8DA-4B76-9E5E-546635639CD5Q37467929-8E2D28EE-B8F7-4C8E-A32D-AF121CBA53B4Q38070400-55DDFEE4-F666-47F2-B2A7-1C758B7F2014Q38366271-EBEFF5A9-FFE2-48A9-BF12-CF067FCD1D21Q40003326-248EE76D-74DC-470E-8C29-87DE1D589C7FQ40045483-34DB84FE-EC9D-4A4D-9A41-F09B7A23BC84Q45969420-197A29C9-8B0C-4964-B440-80E91915FDE3Q46107948-F5096425-C23E-4D3C-958E-39F2A92613E7Q46669769-73B4E665-EBD3-4EEB-984E-1D7D44A6F51DQ48335945-F960A6F4-488A-4947-A746-696B4833E51FQ48466996-03FCAA27-1BDC-4593-A339-BA00FD499752Q54122835-8751564F-EFB3-42AB-BBBA-BF3C43CED568
P2860
Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+).
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Rat model of Parkinson's disea ...... hyl-4-phenylpyridinium (MPP+).
@ast
Rat model of Parkinson's disea ...... hyl-4-phenylpyridinium (MPP+).
@en
type
label
Rat model of Parkinson's disea ...... hyl-4-phenylpyridinium (MPP+).
@ast
Rat model of Parkinson's disea ...... hyl-4-phenylpyridinium (MPP+).
@en
prefLabel
Rat model of Parkinson's disea ...... hyl-4-phenylpyridinium (MPP+).
@ast
Rat model of Parkinson's disea ...... hyl-4-phenylpyridinium (MPP+).
@en
P2093
P1476
Rat model of Parkinson's disea ...... hyl-4-phenylpyridinium (MPP+).
@en
P2093
P304
P356
10.1016/J.EXPNEUROL.2006.02.002
P407
P577
2006-03-20T00:00:00Z